Yuval Binur

Orchestra Medical Ventures LLC (Orchestra Medical Ventures) is a venture capital firm founded in 2001 by Richard P. Geoffrion and Yuval Binur. The firm is headquartered in New Hope, Pennsylvania.

Vital Access Corp. engages in designing and manufacturing of surgical and interventional technologies. The company was founded by Duane Blatter in July 2006 and is headquartered in Salt Lake City, UT.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

Accelerated Technologies, Inc. creates and accelerates cardiovascular medical devices. The company was founded by Martin B. Leon and Yuval Binur and is headquartered in Hackensack, NJ.

Medica Venture Partners (Medica Venture Partners) is a venture capital firm founded in 1995 by Yuval Binur, Ehud Geller and Jonathan Fleming. The firm is headquartered in Israel.

Zongmu Technology (Shanghai) Co. Ltd. engages in the supply of autonomous driving (AD) and advanced driver assistance systems (ADAS) technologies and products. Its products include autonomous valet parking, automatic parking assistant, advanced driving assistance system, Zongmu auto-learning mapping and service, and Zongmu end-user assured cloud system. The company was founded by Rui Tang and Wan Shou Li in January 10, 2013 and is headquartered in Shanghai, China.

X-Cell Medical, Inc. develops drugs for cardiovascular clinical applications. It focuses on delivery of drugs with safety and efficacy profiles for cardiovascular indications including restenosis, myocardial infarction and vulnerable plaque. The company was founded in 2002 and is headquartered in Monmouth Junction, NJ.

superDimension Ltd. develops and markets pulmonology devices. Its devices enable the diagnosis and potentially the treatment of distal lung disease. The firm develops and markets catheter-based devices for use in the invasive diagnosis and treatment of early stage lung cancer and other diseases, using the patient's natural airways to avoid surgery. The company was founded by Pinchas Gilboa in 1995 and is headquartered in Herzliya, Israel.

SuperDimension, Inc. used to develop and market pulmonology devices. It developed and used to market catheter-based devices for use in the invasive diagnosis and treatment of early stage lung cancer and other diseases, using the patient's natural airways to avoid surgery. The company was founded by Pinhas Gilboa in 1995 and was headquartered in Minneapolis, MN.